Mi Wang

Mi Wang is the Director at Nanjing HTZ Biopharmaceutical Public Platform Co. Ltd and has been in this role since 2014. They have a strong background in biochemistry, molecular biology, and cell biology, with extensive experience in drug discovery and assay development. Prior to their current position, Mi worked as a Senior Scientist at GenScript Corporation from 2012 and at HD Biosciences from 2010 to 2012. They also completed a postdoctoral fellowship at the University of Illinois at Urbana-Champaign in 2009. Mi holds a PhD in Biochemistry from Auburn University and a Master’s degree in Biochemical Engineering from Nanjing University of Technology.